bm 13505 has been researched along with Coronary Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M | 1 |
Lefer, AM | 1 |
Earl, CQ; Egan, JW; Griswold, DE; Hillegass, LM; Marshall, PJ; Smith, EF | 1 |
Bhat, AM; Lefer, AM; Osborne, JA; Sacks, H | 1 |
Lefer, AM; Osborne, JA | 1 |
Ney, P; Schrör, K; Thiemermann, C | 1 |
Farber, NE; Gross, GJ; Pieper, GM | 1 |
7 other study(ies) available for bm 13505 and Coronary Disease
Article | Year |
---|---|
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine | 1991 |
Role of thromboxane A2 in myocardial ischemia and circulatory shock.
Topics: Animals; Cats; Coronary Disease; Myocardial Reperfusion Injury; Phenylacetates; Platelet Aggregation; Rabbits; Shock; Sulfonamides; Thromboxane A2; Thromboxanes | 1989 |
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Disease; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1989 |
Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
Topics: Acute Disease; Animals; Blood Pressure; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Heart Rate; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Phenylacetates; Sulfonamides; Thromboxanes | 1989 |
Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Coronary Disease; Coronary Vessels; Creatine Kinase; Male; Phenylacetates; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Reference Values; Sulfonamides; Thromboxanes | 1988 |
The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
Topics: Adenosine Triphosphate; Animals; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Female; Heart Rate; Hemodynamics; Leukocytosis; Male; Myocardial Contraction; Myocardium; Neutrophils; Oxygen; Phenylacetates; Platelet Count; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes | 1988 |
Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Energy Metabolism; Female; Heart; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Phenylacetates; Phosphates; Prostaglandins; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase | 1988 |